2m 2m 2m 2m 2m 2m 2m
Healthcare REIT-A (HR)
NYSE
$20.32+$0.16 (+0.79%)
Price as of Jun 23, 2026 6:32 PM EDT- $7.0BMarket Cap
- 37.31%1-Year Change
- REIT - Healthcare FacilitiesIndustry
Healthcare REIT-A (HR)
$20.32+$0.16 (+0.79%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B -6.92% | 1.3B -5.62% | 1.3B +44.08% | 932.6M +21.58% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.2B -6.92% | 1.3B -5.62% | 1.3B +44.08% | 932.6M +21.58% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 564.0M -16.47% | 675.2M -7.60% | 730.7M +61.28% | 453.1M +59.93% | |
Total Operating Expenses | 72.6M -12.69% | 83.1M +42.32% | 58.4M +10.75% | 52.7M -92.54% | |
Operating Profit | -246.1M -62.40% | -654.5M +135.21% | -278.3M -780.39% | 40.9M -58.28% | |
Interest Income | 6.3M -21.25% | 8.0M -9.09% | 8.8M N/A | N/A N/A | |
Interest Expense | -229,000 -61.58% | -596,000 -99.77% | -258.6M +76.28% | -146.7M +58.14% | |
Interest Income and Expense and Net | 6.1M -18.00% | 7.4M +102.96% | -249.8M +70.28% | -146.7M +63.70% | |
Total Nonoperating Income and Expense | -342.4M -50.90% | -697.4M +107.41% | -336.2M -621.13% | 64.5M +13,202.89% | |
Income before Taxes | -246.1M -62.40% | -654.5M +135.21% | -278.3M -780.39% | 40.9M -58.28% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 470.8M +114.47% | 219.5M +41.53% | 155.1M -71.31% | 540.5M N/A | |
Net Income | -246.1M -62.40% | -654.5M +135.21% | -278.3M -780.39% | 40.9M -58.28% | |
Net Income from Continuing Operations Applicable to Common | -246.1M -62.40% | -654.5M +135.21% | -278.3M -780.39% | 40.9M -58.28% | |
Basic EPS and Net Income | -0.71 -60.77% | -1.81 +144.59% | -0.74 -593.33% | 0.15 -66.67% | |
Diluted EPS and Net Income | -0.71 -60.77% | -1.81 +144.59% | -0.74 -593.33% | 0.15 -65.91% | |
Basic Weighted Average Shares | 349.8M -4.31% | 365.6M -3.53% | 378.9M +50.16% | 252.4M +15.00% | |
Diluted Weighted Average Shares | 349.8M -4.31% | 365.6M -3.53% | 378.9M +49.26% | 253.9M +13.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 26.2M -62.02% | 68.9M +168.17% | 25.7M -57.84% | 61.0M +16.44% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 26.2M -62.02% | 68.9M +168.17% | 25.7M -57.84% | 61.0M +16.44% | |
Total Current Assets | 487.8M -3.88% | 507.5M -14.33% | 592.4M +26.04% | 470.0M +797.73% | |
Accumulated Depreciation | 2.4B -3.46% | 2.5B +11.53% | 2.2B +35.35% | 1.6B +2.93% | |
Property and Plant and Equipment and Net | 7.9B -15.36% | 9.3B -16.52% | 11.2B -9.99% | 12.4B +101.24% | |
Total Long-Term Assets | 487.8M -3.88% | 507.5M -14.33% | 592.4M +26.04% | 470.0M N/A | |
Total Assets | 9.2B -13.52% | 10.7B -15.72% | 12.6B -8.75% | 13.8B +101.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 600.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 211.1M -5.14% | 222.5M +4.96% | 212.0M -13.13% | 244.0M +23.20% | |
Total Long-Term Debt | 3.9B -16.11% | 4.7B -6.65% | 5.0B -6.67% | 5.4B +76.74% | |
Total Long-Term Liabilities | 4.1B -16.63% | 4.9B -6.46% | 5.2B -7.23% | 5.6B +74.38% | |
Total Liabilities | 4.5B -15.17% | 5.3B -6.46% | 5.7B -7.35% | 6.2B +73.97% | |
Retained Earnings | 5.2M +533.33% | -1.2M -88.79% | -10.7M -609.52% | 2.1M +129.83% | |
Total Stockholders Equity | 4.6B -11.80% | 5.2B -23.27% | 6.8B -9.89% | 7.6B +132.41% | |
Total Shares Outstanding | 351.6M +0.31% | 350.5M -7.99% | 381.0M +0.10% | 380.6M +66.28% | |
Cash Flow | |||||
Cash from Operating Activities | 457.1M -8.88% | 501.6M +0.36% | 499.8M +83.25% | 272.7M -29.27% | |
Capital Expenditures | 100,000 N/A | 0 -100.00% | 49.2M -87.78% | 402.5M +52.28% | |
Cash from Investing Activities | 710.8M -21.10% | 900.9M +158.04% | 349.1M -78.64% | 1.6B +508.74% | |
Dividends Paid | 386.9M -15.49% | 457.9M -3.05% | 472.2M +66.45% | 283.7M +0.67% | |
Cash from Financing Activities | -1.2B -10.94% | -1.4B +53.73% | -884.2M -52.44% | -1.9B +3,817.92% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -20.84% -59.61% | -51.60% +149.20% | -20.71% -572.22% | 4.39% -65.68% | |
Return on Assets | -2.48% -55.92% | -5.62% +167.52% | -2.10% -632.73% | 0.39% -72.48% | |
Return on Equity | -5.00% -53.98% | -10.86% +180.78% | -3.87% -611.90% | 0.76% -75.22% | |
Revenue Growth | -6.92% +23.24% | -5.61% -112.74% | 44.08% +104.24% | 21.58% +467.44% | |
Current Ratio | 2.31 +1.32% | 2.28 -18.38% | 2.79 +45.09% | 1.93 +628.68% | |
Cash Ratio | 0.12 -59.96% | 0.31 +155.53% | 0.12 -51.48% | 0.25 -5.49% | |
Debt-to-Equity Ratio | 0.98 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.49 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow